Mrs. Elizabeth Margaret Wilson, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1150 W Fairview St, Colfax, WA 99111 Phone: 509-397-9214 |
Cassidy A Kobialka, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1200 W Fairview St, Colfax, WA 99111 Phone: 509-397-5733 |
Janine Brooke Peca Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1200 W Fairview St, Colfax, WA 99111 Phone: 509-397-5733 |
Jessica Hunter Yates Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1207 N Morton St, Colfax, WA 99111 Phone: 509-397-2181 |
News Archive
Hygeia Therapeutics, Inc. announced today the successful completion of a series of preclinical studies for HYG-102, their lead product for the treatment of vulvar and vaginal atrophy (VVA) and age-related skin fragility. HYG-102 is the lead biodegradable estrogenic candidate in a portfolio of 23 similar compounds licensed from the laboratory of Dr. Richard Hochberg of Yale University.
Thousands of people with disabilities, their families, caregivers, seniors, veterans with disabilities and healthcare professionals are expected to attend Abilities Expo on Friday, August 27, through Sunday, August 29, 2010 at Reliant Center. Admission is free and show hours will be Friday 11 am to 5 pm, Saturday 10 am to 5 pm and Sunday 11 am to 4 pm.
AFFiRiS' Alzheimer's vaccine candidate AD02 showed indicative evidence for potential efficacy in a phase I clinical trial. This was demonstrated by the analysis of the data from secondary clinical study endpoints.
Teenage women who are obese may be more than twice as likely to develop multiple sclerosis (MS) as adults compared to female teens who are not obese, according to a study published in the November 10, 2009, print issue of Neurology-, the medical journal of the American Academy of Neurology.
Researchers have urged doctors to be cautious over withdrawal of long-acting beta-2 agonist therapy in patients with asthma controlled by this type of bronchodilator in combination with an inhaled corticosteroid, after finding the approach often results in destabilization of their condition.
› Verified 2 days ago